Major studies reveal improved treatment for children with Group 3 medulloblastoma

Vital research findings pointing to improved treatment for children with Group 3 medulloblastoma brain tumors have been revealed in two major studies published in the journal Neuro-Oncology.

Jazz Pharmaceuticals CEO and co-founder Bruce Cozadd is retiring

Jazz Pharmaceuticals CEO Bruce Cozadd is ready to play his outro. On Monday, Cozadd announced plans to retire, nearly 22 years … Sign up to

December 18, 2024

Employers Struggle with Employee Weight Care as GLP-1 Demand Soars

What You Should Know: Found, a medically assisted weight loss program, released its inaugural State of Weight Care Report from a survey representing 500 large employers

September 13, 2023

Breast Cancer Highlights From ASCO 2023

In this video, Paolo Tarantino, MD, of the Dana-Farber Cancer Institute in Boston, provides an overview of key updates in breast cancer from the recent

July 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.